Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern
Liane Dupont, Luke B. Snell, Carl Graham, et al.
Nature Microbiology (2021) Vol. 6, Iss. 11, pp. 1433-1442
Open Access | Times Cited: 106

Showing 1-25 of 106 citing articles:

Omicron Variant (B.1.1.529): Infectivity, Vaccine Breakthrough, and Antibody Resistance
Jiahui Chen, Rui Wang, Nancy Benovich Gilby, et al.
Journal of Chemical Information and Modeling (2022) Vol. 62, Iss. 2, pp. 412-422
Open Access | Times Cited: 640
T cell responses to SARS-CoV-2 spike cross-recognize Omicron
Roanne Keeton, Marius B. Tincho, Amkele Ngomti, et al.
Nature (2022) Vol. 603, Iss. 7901, pp. 488-492
Open Access | Times Cited: 546
Main protease mutants of SARS-CoV-2 variants remain susceptible to nirmatrelvir
Sven Ullrich, Kasuni B. Ekanayake, Gottfried Otting, et al.
Bioorganic & Medicinal Chemistry Letters (2022) Vol. 62, pp. 128629-128629
Open Access | Times Cited: 182
Longitudinal analysis of antibody dynamics in COVID-19 convalescents reveals neutralizing responses up to 16 months after infection
Yang Yang, Minghui Yang, Yun Peng, et al.
Nature Microbiology (2022) Vol. 7, Iss. 3, pp. 423-433
Open Access | Times Cited: 105
Escape from recognition of SARS-CoV-2 variant spike epitopes but overall preservation of T cell immunity
Catherine Riou, Roanne Keeton, Thandeka Moyo-Gwete, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 631
Open Access | Times Cited: 102
Mapping SARS-CoV-2 antigenic relationships and serological responses
Samuel Wilks, Barbara Mühlemann, Xiaoying Shen, et al.
Science (2023) Vol. 382, Iss. 6666
Open Access | Times Cited: 100
Convalescent Plasma for Covid-19–Induced ARDS in Mechanically Ventilated Patients
Benoît Misset, Michaël Piagnerelli, Eric A. J. Hoste, et al.
New England Journal of Medicine (2023) Vol. 389, Iss. 17, pp. 1590-1600
Open Access | Times Cited: 52
Omicron (B.1.1.529): Infectivity, vaccine breakthrough, and antibody resistance.
Jiahui Chen, Rui Wang, Nancy Benovich Gilby, et al.
arXiv (Cornell University) (2021)
Open Access | Times Cited: 66
Mapping SARS-CoV-2 antigenic relationships and serological responses
Samuel Wilks, Barbara Mühlemann, Xiaoying Shen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 60
Persistent Laplacian projected Omicron BA.4 and BA.5 to become new dominating variants
Jiahui Chen, Yuchi Qiu, Rui Wang, et al.
Computers in Biology and Medicine (2022) Vol. 151, pp. 106262-106262
Open Access | Times Cited: 54
Risk of SARS-CoV-2 reinfections in children: a prospective national surveillance study between January, 2020, and July, 2021, in England
Anna Mensah, Helen Campbell, Julia Stowe, et al.
The Lancet Child & Adolescent Health (2022) Vol. 6, Iss. 6, pp. 384-392
Open Access | Times Cited: 47
Recent insights into SARS‐CoV‐2 omicron variant
Severino Jefferson Ribeiro da Silva, Alain Kohl, Lindomar Pena, et al.
Reviews in Medical Virology (2022) Vol. 33, Iss. 1
Open Access | Times Cited: 44
Hybrid Immunity to SARS-CoV-2 from Infection and Vaccination—Evidence Synthesis and Implications for New COVID-19 Vaccines
Júlia Spinardi, Amit Srivastava
Biomedicines (2023) Vol. 11, Iss. 2, pp. 370-370
Open Access | Times Cited: 35
Antigenic cartography using variant-specific hamster sera reveals substantial antigenic variation among Omicron subvariants
Barbara Mühlemann, Jakob Trimpert, Felix Walper, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 32
Open Access | Times Cited: 10
ChAdOx1 nCoV-19 (AZD1222) or nCoV-19-Beta (AZD2816) protect Syrian hamsters against Beta Delta and Omicron variants
Neeltje van Doremalen, Jonathan E. Schulz, Danielle R. Adney, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 37
Broad Neutralization of SARS-CoV-2 Variants, Including Omicron, following Breakthrough Infection with Delta in COVID-19-Vaccinated Individuals
Thomas Lechmere, Luke B. Snell, Carl Graham, et al.
mBio (2022) Vol. 13, Iss. 2
Open Access | Times Cited: 33
Detection of Antibody Responses Against SARS-CoV-2 in Plasma and Saliva From Vaccinated and Infected Individuals
Jéromine Klingler, Gregory S. Lambert, Vincenza Itri, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 35
The SARS-CoV-2 Delta variant induces an antibody response largely focused on class 1 and 2 antibody epitopes
Allison J. Greaney, Rachel Eguia, Tyler N. Starr, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 6, pp. e1010592-e1010592
Open Access | Times Cited: 25
Clinical course impacts early kinetics,magnitude, and amplitude of SARS-CoV-2 neutralizing antibodies beyond 1 year after infection
Edwards Pradenas, Benjamin Trinité, Víctor Urrea, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 2, pp. 100523-100523
Open Access | Times Cited: 24
In Silico Screening of Bioactive Compounds of Representative Seaweeds to Inhibit SARS-CoV-2 ACE2-Bound Omicron B.1.1.529 Spike Protein Trimer
Muruganantham Bharathi, Bhagavathi Sundaram Sivamaruthi, Periyanaina Kesika, et al.
Marine Drugs (2022) Vol. 20, Iss. 2, pp. 148-148
Open Access | Times Cited: 24
Natural SARS-CoV-2 Infection Affects Neutralizing Activity in Saliva of Vaccinees
Micaela Garziano, Olga Utyro, Mariacristina Poliseno, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 24
Neutralizing Efficacy of Encapsulin Nanoparticles against SARS-CoV2 Variants of Concern
Sara Khaleeq, Nayanika Sengupta, Sahil Kumar, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 346-346
Open Access | Times Cited: 14
SARS-CoV-2 spike-specific TFH cells exhibit unique responses in infected and vaccinated individuals
Rongzhang He, Xingyu Zheng, Jian Zhang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 14
SARS-CoV-2 rapidly evolves lineage-specific phenotypic differences when passaged repeatedly in immune-naïve mice
Julian Daniel Sunday Willett, Annie Gravel, Isabelle Dubuc, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 5
Induction of Superior Systemic and Mucosal Protective Immunity to SARS-CoV-2 by Nasal Administration of a VSV–ΔG–Spike Vaccine
Yfat Yahalom-Ronen, Sharon Melamed, Boaz Politi, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 491-491
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top